LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 225

Search options

  1. Article ; Online: Investigating locations of recurrences with MRI after CRS-HIPEC for colorectal peritoneal metastases.

    Rijsemus, C J V / Kok, N F M / Aalbers, A G J / Grotenhuis, B A / Berardi, E / Snaebjornsson, P / Lambregts, D M J / Beets-Tan, R G H / Lahaye, M J

    European journal of radiology

    2024  Volume 175, Page(s) 111478

    Abstract: ... where the peritoneum was damaged due to earlier resections or other surgical procedures (e.g. inserted surgical ...

    Abstract Purpose: Patients with colorectal peritoneal metastases (PM) treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are at high risk of recurrent disease. Understanding where and why recurrences occur is the first step in finding solutions to reduce recurrence rates. Although diffusion-weighted (DW) MRI is not routinely used in the follow-up of CRC patients, it has a clear advantage over CT in detecting the location and spread of (recurrent) PM. This study aimed to identify common locations of recurrence in CRC patients after CRS-HIPEC with MRI.
    Method: This was a single-centre retrospective study of patients with recurrent PM after CRS-HIPEC performed between January 2016 and August 2020. Patients were eligible for inclusion if they had both an MRI preoperatively (MRI1) and at the time of recurrent disease (MRI2). Two abdominal radiologists reviewed in consensus and categorized recurrences according to their location on MRI2 and in correlation with previous disease location on prior imaging (MRI1) and the surgical report of the CRS-HIPEC.
    Results: Thirty patients were included, with a median surgical PCI of 7 (range 3-21) at the time of primary CRS-HIPEC. In total, 68 recurrent metastases were detected on MRI2, of which 14 were extra-peritoneal. Of the remaining 54 PM, 42 (78%) occurred where the peritoneum was damaged due to earlier resections or other surgical procedures (e.g. inserted surgical abdominal drains). Most recurrent metastases were found in the mesentery, lower abdomen/pelvis and abdominal wall (87%).
    Conclusions: Most recurrent PMs appeared in the mesentery, lower abdomen/pelvis and abdominal wall, especially where the peritoneum was previously damaged.
    Language English
    Publishing date 2024-04-22
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 138815-0
    ISSN 1872-7727 ; 0720-048X
    ISSN (online) 1872-7727
    ISSN 0720-048X
    DOI 10.1016/j.ejrad.2024.111478
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Imaging in the era of risk-adapted treatment in Colon cancer.

    Lahaye, Max J / Lambregts, Doenja M J / Aalbers, Arend G J / Snaebjornsson, Petur / Beets-Tan, R G H / Kok, Niels F M

    The British journal of radiology

    2024  

    Abstract: The treatment landscape for patients with colon cancer is continuously evolving. Risk-adapted treatment strategies, including neoadjuvant chemotherapy and immunotherapy, are slowly finding their way into clinical practice and guidelines. Radiologists are ...

    Abstract The treatment landscape for patients with colon cancer is continuously evolving. Risk-adapted treatment strategies, including neoadjuvant chemotherapy and immunotherapy, are slowly finding their way into clinical practice and guidelines. Radiologists are pivotal in guiding clinicians toward the most optimal treatment for each colon cancer patient. This review provides an overview of recent and upcoming advances in the diagnostic management of colon cancer and the radiologist's role in the multidisciplinary approach to treating colon cancer.
    Language English
    Publishing date 2024-04-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 2982-8
    ISSN 1748-880X ; 0007-1285
    ISSN (online) 1748-880X
    ISSN 0007-1285
    DOI 10.1093/bjr/tqae061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Whole-body MRI with diffusion-weighted imaging as an adjunct to

    Willemse, Jeroen R J / Lahaye, Max J / Kok, Niels F M / Grotenhuis, Brechtje A / Aalbers, Arend G J / Beets, Geerard L / Rijsemus, Charlotte / Maas, Monique / van Golen, Larissa W / Beets-Tan, Regina G H / Lambregts, Doenja M J

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

    2023  Volume 26, Issue 2, Page(s) 290–299

    Abstract: Aim: The aim was to explore how findings of whole-body MRI including diffusion-weighted imaging (DW-MRI) compared to the routine diagnostic workup with CT and/or : Method: This was an exploratory retrospective analysis of 55 patients with a clinical ... ...

    Abstract Aim: The aim was to explore how findings of whole-body MRI including diffusion-weighted imaging (DW-MRI) compared to the routine diagnostic workup with CT and/or
    Method: This was an exploratory retrospective analysis of 55 patients with a clinical suspicion of recurrent CRC who underwent DW-MRI following CT and/or FDG-PET/CT. Two readers in consensus interpreted all clinical imaging reports and converted each described lesion into a confidence score (1 = definitely benign to 5 = definitely malignant). DW-MRI findings were compared to the most recent previous CT or PET/CT. Any discrepant or additional DW-MRI findings were documented and compared with histology and/or clinical follow-up (if available).
    Results: Whole-body MRI including diffusion-weighted imaging (DW-MRI) resulted in discrepant/additional findings in 26/55 (47%) cases; 23/37 (62%) compared to previous CT and 3/18 (17%) compared to previous PET/CT. These included 10 cases where DW-MRI converted previously inconclusive CT (n = 8) or PET/CT (n = 2) findings into a conclusive diagnosis, one where it contradicted a previous CT diagnosis of recurrence, five where DW-MRI diagnosed recurrent disease not previously reported on CT and 10 cases where DW-MRI detected additional lesions compared to CT (n = 9) or PET/CT (n = 1). Eighty-eight per cent of cases with discrepant/additional findings concerned patients with recurrent/metachronous peritoneal metastases. In total, DW-MRI resulted in 42 discrepant/additional lesions; the DW-MRI diagnosis was correct in 76% of these lesions and incorrect (false positive) in 7%. In the remaining 17%, no standard of reference was available.
    Conclusions: This explorative study suggests that DW-MRI may be of added value to patients with a clinical suspicion for recurrent CRC, in particular to identify patients with peritoneal metastases. DW-MRI mainly has potential as a 'problem-solver' in patients with inconclusive or negative findings on previous imaging (in particular CT) and to detect additional disease sites in patients already diagnosed with recurrent disease.
    MeSH term(s) Humans ; Diffusion Magnetic Resonance Imaging/methods ; Positron Emission Tomography Computed Tomography/methods ; Fluorodeoxyglucose F18 ; Retrospective Studies ; Peritoneal Neoplasms ; Magnetic Resonance Imaging ; Positron-Emission Tomography/methods ; Colorectal Neoplasms/diagnostic imaging ; Colorectal Neoplasms/pathology ; Radiopharmaceuticals
    Chemical Substances Fluorodeoxyglucose F18 (0Z5B2CJX4D) ; Radiopharmaceuticals
    Language English
    Publishing date 2023-12-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 1440017-0
    ISSN 1463-1318 ; 1462-8910
    ISSN (online) 1463-1318
    ISSN 1462-8910
    DOI 10.1111/codi.16840
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book ; Online: Deliverable 6

    Aalbers, C.B.E.M. / Gerritsen, A.L. / Nuesink, J.G. / Oomkens, Jeroen / Korteweg, Lisa

    Final “To-be situation” voor de aanpak van riviergebiedsbeheer

    2022  

    Keywords Life Science
    Language Dutch
    Publisher Trinomics
    Publishing country nl
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article: Correction: Groen et al. Use of Image-Guided Surgical Navigation during Resection of Locally Recurrent Rectal Cancer.

    Groen, Harald C / den Hartog, Anne G / Heerink, Wouter J / Kuhlmann, Koert F D / Kok, Niels F M / van Veen, Ruben / Hiep, Marijn A J / Snaebjornsson, Petur / Grotenhuis, Brechtje A / Beets, Geerard L / Aalbers, Arend G J / Ruers, Theo J M

    Life (Basel, Switzerland)

    2023  Volume 13, Issue 3

    Abstract: The authors wish to make the following corrections to this paper [ ... ]. ...

    Abstract The authors wish to make the following corrections to this paper [...].
    Language English
    Publishing date 2023-03-02
    Publishing country Switzerland
    Document type Published Erratum
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life13030678
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book ; Online: Deliverable 3

    Aalbers, C.B.E.M. / Gerritsen, A.L. / Nuesink, J.G. / Oomkens, Jeroen / Korteweg, Lisa

    Identificeren van einddoelstellingen voor het gebiedsbeheer van de Noordwaard

    2022  

    Keywords Life Science
    Language Dutch
    Publisher Trinomics
    Publishing country nl
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts.

    van Geffen, E G M / Langhout, J M A / Hazen, S J A / Sluckin, T C / van Dieren, S / Beets, G L / Beets-Tan, R G H / Borstlap, W A A / Burger, J W A / Horsthuis, K / Intven, M P W / Aalbers, A G J / Havenga, K / Marinelli, A W K S / Melenhorst, J / Nederend, J / Peulen, H M U / Rutten, H J T / Schreurs, W H /
    Tuynman, J B / Verhoef, C / de Wilt, J H W / Marijnen, C A M / Tanis, P J / Kusters, M / On Behalf Of The Dutch Snapshot Research Group

    European journal of cancer (Oxford, England : 1990)

    2024  Volume 202, Page(s) 114021

    Abstract: Background: In the Netherlands, use of neoadjuvant radiotherapy for rectal cancer declined after guideline revision in 2014. This decline is thought to affect the clinical nature and treatability of locally recurrent rectal cancer (LRRC). Therefore, ... ...

    Abstract Background: In the Netherlands, use of neoadjuvant radiotherapy for rectal cancer declined after guideline revision in 2014. This decline is thought to affect the clinical nature and treatability of locally recurrent rectal cancer (LRRC). Therefore, this study compared two national cross-sectional cohorts before and after the guideline revision with the aim to determine the changes in treatment and survival of LRRC patients over time.
    Methods: Patients who underwent resection of primary rectal cancer in 2011 (n = 2094) and 2016 (n = 2855) from two nationwide cohorts with a 4-year follow up were included. Main outcomes included time to LRRC, synchronous metastases at time of LRRC diagnosis, intention of treatment and 2-year overall survival after LRRC.
    Results: Use of neoadjuvant (chemo)radiotherapy for the primary tumour decreased from 88.5% to 60.0% from 2011 to 2016. The 3-year LRRC rate was not significantly different with 5.1% in 2011 (n = 114, median time to LRRC 16 months) and 6.3% in 2016 (n = 202, median time to LRRC 16 months). Synchronous metastasis rate did not significantly differ (27.2% vs 33.7%, p = 0.257). Treatment intent of the LRRC shifted towards more curative treatment (30.4% vs. 47.0%, p = 0.009). In the curatively treated group, two-year overall survival after LRRC diagnoses increased from 47.5% to 78.7% (p = 0.013).
    Conclusion: Primary rectal cancer patients in 2016 were treated less often with neoadjuvant (chemo)radiotherapy, while LRRC rates remained similar. Those who developed LRRC were more often candidate for curative intent treatment compared to the 2011 cohort, and survival after curative intent treatment also improved substantially.
    MeSH term(s) Humans ; Cross-Sectional Studies ; Neoplasm Recurrence, Local/pathology ; Rectal Neoplasms/therapy ; Rectal Neoplasms/pathology ; Combined Modality Therapy ; Neoadjuvant Therapy ; Retrospective Studies
    Language English
    Publishing date 2024-03-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 82061-1
    ISSN 1879-0852 ; 0277-5379 ; 0959-8049 ; 0964-1947
    ISSN (online) 1879-0852
    ISSN 0277-5379 ; 0959-8049 ; 0964-1947
    DOI 10.1016/j.ejca.2024.114021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Azacytidine Treatment for VEXAS Syndrome.

    Raaijmakers, Marc H G P / Hermans, Maud / Aalbers, Anna / Rijken, Melissa / Dalm, Virgil A S H / van Daele, Paul / Valk, Peter J M

    HemaSphere

    2021  Volume 5, Issue 12, Page(s) e661

    Language English
    Publishing date 2021-11-17
    Publishing country United States
    Document type Journal Article
    ISSN 2572-9241
    ISSN (online) 2572-9241
    DOI 10.1097/HS9.0000000000000661
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Diagnostic performance of MRI for staging peritoneal metastases in patients with colorectal cancer after neoadjuvant chemotherapy.

    Rijsemus, C J V / Kok, N F M / Aalbers, A G J / Buffart, T E / Fijneman, R J A / Snaebjornsson, P / Engbersen, M P / Lambregts, D M J / Beets-Tan, R G H / Lahaye, M J

    European journal of radiology

    2022  Volume 149, Page(s) 110225

    Abstract: Introduction: MRI improves the selection of patients with colorectal cancer (CRC) and peritoneal metastases (PM) for cytoreductive surgery by accurately assessing the extent of PM reflected as the peritoneal cancer index (PCI). The performance of MRI ... ...

    Abstract Introduction: MRI improves the selection of patients with colorectal cancer (CRC) and peritoneal metastases (PM) for cytoreductive surgery by accurately assessing the extent of PM reflected as the peritoneal cancer index (PCI). The performance of MRI after neoadjuvant chemotherapy (NACT) for staging PM, however is unknown. The purpose of this study was to determine whether MRI could also accurately determine the PCI after NACT.
    Materials and methods: This was a single-centre, retrospective study of patients with PM from CRC or appendiceal origin who received NACT followed by diffusion-weighted (DW)-MRI and surgery from January 2016 to February 2021. Two radiologists assessed the PCI on restaging DW-MRI (mriPCI). The reference standard was the surgical PCI (sPCI). The main outcome was the diagnostic performance of restaging DW-MRI in predicting whether patients were eligible for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), defined as a PCI < 21 with metastases on resectable locations. If CRS-HIPEC was performed, the resected peritoneal lesions were assessed and correlated with the final pathological PCI (pPCI).
    Results: Thirty-three patients were included. Both readers correctly detected all 23 patients with resectable disease. Eight out of ten patients with unresectable disease during staging surgery were detected by both readers with MRI. The intraclass correlation (ICC) between both readers was excellent (0⋅87 (95% CI: 0⋅75 to 0⋅93)). The ICC between pPCI and mriPCI was 0⋅74 (0⋅49-0⋅88) and 0⋅82 (0⋅66-0⋅91) for the 2 readers. Surgical PCI (sPCI) had a similar correlation as mriPCI with pPCI 0⋅82 (0⋅62- 0⋅92)) and 0⋅81 (0⋅57-0⋅92)).
    Conclusion: DW-MRI is a promising tool to reassess the peritoneal cancer index after neoadjuvant chemotherapy.
    MeSH term(s) Colorectal Neoplasms/pathology ; Combined Modality Therapy ; Cytoreduction Surgical Procedures ; Diffusion Magnetic Resonance Imaging ; Humans ; Hyperthermia, Induced ; Magnetic Resonance Imaging ; Neoadjuvant Therapy ; Peritoneal Neoplasms/diagnostic imaging ; Peritoneal Neoplasms/drug therapy ; Retrospective Studies ; Survival Rate
    Language English
    Publishing date 2022-02-19
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 138815-0
    ISSN 1872-7727 ; 0720-048X
    ISSN (online) 1872-7727
    ISSN 0720-048X
    DOI 10.1016/j.ejrad.2022.110225
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial.

    Bakkers, C / Rovers, K P / Rijken, A / Simkens, G A A M / Bonhof, C S / Nienhuijs, S W / Burger, J W A / Creemers, G J M / Brandt-Kerkhof, A R M / Tuynman, J B / Aalbers, A G J / Wiezer, M J / de Reuver, P R / van Grevenstein, W M U / Hemmer, P H J / Punt, C J A / Tanis, P J / Mols, F / de Hingh, I H J T

    Annals of surgical oncology

    2023  Volume 30, Issue 5, Page(s) 2678–2688

    Abstract: Background: As part of a randomized phase II trial in patients with isolated resectable colorectal peritoneal metastases (CPMs), the present study compared patient-reported outcomes (PROs) of patients treated with perioperative systemic therapy versus ... ...

    Abstract Background: As part of a randomized phase II trial in patients with isolated resectable colorectal peritoneal metastases (CPMs), the present study compared patient-reported outcomes (PROs) of patients treated with perioperative systemic therapy versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) alone. Also, PROs of patients receiving perioperative systemic therapy were explored.
    Patients and methods: Eligible patients were randomized to perioperative systemic therapy (experimental) or CRS-HIPEC alone (control). PROs were assessed using EORTC QLQ-C30, QLQ-CR29, and EQ-5D-5L questionnaires at baseline, after neoadjuvant treatment (experimental), and at 3 and 6 months postoperatively. Linear mixed modeling was used to compare five predefined PROs (visual analog scale, global health status, physical functioning, fatigue, C30 summary score) between arms and to longitudinally analyze PROs in the experimental arm.
    Results: Of 79 analyzed patients, 37 (47%) received perioperative systemic therapy. All predefined PROs were comparable between arms at all timepoints and returned to baseline at 3 or 6 months postoperatively. The experimental arm had worsening of fatigue [mean difference (MD) + 14, p = 0.001], loss of appetite (MD + 15, p = 0.003), hair loss (MD + 18, p < 0.001), and loss of taste (MD + 27, p < 0.001) after neoadjuvant treatment. Except for loss of appetite, these PROs returned to baseline at 3 or 6 months postoperatively.
    Conclusions: In patients with resectable CPM randomized to perioperative systemic therapy or CRS-HIPEC alone, PROs were comparable between arms and returned to baseline postoperatively. Together with the trial's previously reported feasibility and safety data, these findings show acceptable tolerability of perioperative systemic therapy in this setting.
    MeSH term(s) Humans ; Hyperthermic Intraperitoneal Chemotherapy ; Peritoneal Neoplasms/secondary ; Colorectal Neoplasms/pathology ; Cytoreduction Surgical Procedures ; Hyperthermia, Induced ; Combined Modality Therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Patient Reported Outcome Measures ; Survival Rate
    Language English
    Publishing date 2023-02-08
    Publishing country United States
    Document type Randomized Controlled Trial ; Clinical Trial, Phase II ; Journal Article
    ZDB-ID 1200469-8
    ISSN 1534-4681 ; 1068-9265
    ISSN (online) 1534-4681
    ISSN 1068-9265
    DOI 10.1245/s10434-023-13116-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top